The expression levels of six nrlncRNAs were compared between clinical IDH-wild-type GBM tumor and corresponding peritumor tissues, and we discovered that lncRNA-RP11-131L12.4 was substantially expressed in tumors and had a negative correlation with patient prognosis. This evidence concerns the gene IDH1 and neoplasm.